Mayzent
My Prescription
Payment
Select pharmacy
$2,561.86
Print or send this coupon to your phone
WalgreensPowered byAbout Mayzent
Drug Details
Siponimod, marketed as Mayzent, is a medication designed for adults with relapsing forms of multiple sclerosis (MS). While it does not cure MS, it plays a significant role in reducing the frequency of MS relapses and slowing the progression of the disease. Siponimod functions as a sphingosine 1-phosphate (S1P) receptor modulator. It works by binding to the S1P receptor on white blood cells, preventing these cells from leaving the lymph nodes and attacking the nerves in the brain and spinal cord. This action helps to protect the nervous system and may delay the onset of disability associated with MS. Patients take this medication orally in tablet form. Some common side effects include headache, high blood pressure, and falls. Mayzent is currently available only as a brand-name product. Always consult healthcare professionals for personalized medical advice before starting any new treatment.
Price history for Mayzent
28 Tablets, 0.25MG
Average retail price for Mayzent
Average SaveHealth price for Mayzent
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Mayzent dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 0.25MG | 28 Tablets | $2,581.31 | $92.19 |
| 1MG | 30 Tablets | $11,036.51 | $367.88 |
| 2MG | 15 Tablets | $5,522.26 | $368.15 |
| 2MG | 30 Tablets | $11,036.51 | $367.88 |
Mayzent FAQs
Mayzent (siponimod) is a medication that can help manage multiple sclerosis (MS). It is specifically used to treat adults with relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Mayzent works by modulating the immune system to reduce the frequency of relapses and slow the progression of physical disability. However, its effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider whether Mayzent is a suitable option for their specific condition.
Mayzent is used for the treatment of adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Yes, Mayzent (siponimod) is considered an immunosuppressant. It is used to treat certain forms of multiple sclerosis by modulating the immune system to reduce inflammation and prevent immune cells from attacking the nervous system.
Yes, siponimod is an immunosuppressant. It is used to treat certain forms of multiple sclerosis by modulating the immune system to reduce inflammation and prevent nerve damage.
Weight gain is not commonly reported as a side effect of Mayzent (siponimod). However, individuals may experience side effects differently, and any unexpected changes in weight should be discussed with a healthcare provider to rule out other causes or address any concerns.